CliffBio
small molecule

VERKAZIA

CYCLOSPORINE

Loss of exclusivityJune 2029latest FDA-listed patent expiry
CompanyHARROW EYE LLC

Drug detail

Brand nameVERKAZIA
Active ingredientCYCLOSPORINE
Strength0.1%
Dosage formEMULSION
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalJune 2021
Marketing statusRX

Listed patents

PatentExpiresType
9132071June 2029product
8298568November 2027product
9956289January 2026product
7973081January 2026product
8524779January 2026product
9220694January 2026product
11612658January 2026use U-3560

Regulatory exclusivity

CodeExpires
ODE-358June 2028

More from HARROW EYE LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Not found